RE: PD protocol for evaluation of tests15 Jun 2021 10:29
Flashy500 unfortunately its not me with contacts there.
Mologic are in a weird situation here. On the one side they have the FIND data showing great performance and FIND are respected worldwide including WHO and then they have the Porton down data which is allegedly negative.
FIND opens the doors to LMICs through the WHO (LMICs often use WHO approvals as their regulatory clearance in the absence of a strong regulatory body such as UK MHRA) but Porton Down was supposed to be the door opener to the UK market. Im not really sure what will happen now but with how petty this government is I'm not sure whether the threat of litigation will be a positive or a negative.
I think ODX have been very unfortunate because on their side they have stepped up, done what was asked and prepared well however it appears right now they have little control.